Pfizer Inc. et al v. Dexcel Pharma Technologies Ltd.
| Pfizer Inc., C.P. Pharmaceuticals International C.V., PF PRISM C.V., PBG Puerto Rico LLC and PF PRISM IMB B.V. |
| Dexcel Pharma Technologies Ltd. |
| 1:2023cv01304 |
| November 15, 2023 |
| U.S. District Court for the District of Delaware |
| Colm F Connolly |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 271 Patent Infringement |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on December 1, 2023. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 9 STIPULATION TO EXTEND TIME for Defendant Dexcel Pharma Technologies Ltd. to answer, move, or otherwise respond to the complaint to March 6, 2024 - filed by C.P. Pharmaceuticals International C.V., PBG Puerto Rico LLC, PF PRISM C.V., PF PRISM IMB B.V., Pfizer Inc.. (Dellinger, Megan) |
SO ORDERED, re #9 STIPULATION TO EXTEND TIME for Defendant Dexcel Pharma Technologies Ltd. to answer, move, or otherwise respond to the complaint to March 6, 2024 filed by PF PRISM IMB B.V., PF PRISM C.V., C.P. Pharmaceuticals International C.V., PBG Puerto Rico LLC, Pfizer Inc. Set Answer Deadlines: Dexcel Pharma Technologies Ltd. answer due 3/6/2024. Ordered by Judge Colm F. Connolly on 12/1/2023. (kmd)
|
| Filing 8 STANDING ORDER REGARDING BRIEFING IN ALL CASES (nmf) |
| Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb) |
| Filing 7 AFFIDAVIT of Service for Summons, Complaint and related papers served on Dexcel Pharma Technologies Ltd. on November 16, 2023, filed by C.P. Pharmaceuticals International C.V., PBG Puerto Rico LLC, PF PRISM C.V., PF PRISM IMB B.V., Pfizer Inc.. (Dellinger, Megan) |
| Filing 6 Summons Issued as to Dexcel Pharma Technologies Ltd. on 11/15/2023. (jfm) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Pfizer Inc. for C.P. Pharmaceuticals International C.V., PBG Puerto Rico LLC, PF PRISM IMB B.V., PF Prism C.V. filed by C.P. Pharmaceuticals International C.V., PBG Puerto Rico LLC, PF PRISM IMB B.V., PF PRISM C.V., Pfizer Inc. (jfm) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) RE41,783 E. (jfm) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: October 2, 2023. Date of Expiration of Patent: December 8, 2025.Thirty Month Stay Deadline: 12/8/2025. (jfm) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (jfm) |
| Filing 1 COMPLAINT FOR PATENT INFRINGEMENT filed against Dexcel Pharma Technologies Ltd. (Filing fee $ 402, receipt number ADEDC-4274592.) - filed by Pfizer Inc., C.P. Pharmaceuticals International C.V., PF PRISM C.V., PF PRISM IMB B.V., PBG Puerto Rico LLC. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(jfm) |
Access additional case information on PACER
Use the links below to access additional information about this case on the U.S. Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
